Abstract
Oral squamous cell carcinoma (OSCC) occasionally occurs in young patients and is likely to be distinct from OSCC in older patients. In this retrospective study, we described the clinicopathologic features and outcome of 150 OSCCs that were diagnosed in patients 40-year-old or younger. Most patients (63%) were non-smokers. The most common site of the primary tumor was oral tongue (n = 131, 87%), followed by gingiva (n = 9), buccal mucosa (n = 8) and lip (n = 2). The median patients' age at presentation was 34 (range: 16–40). Seven patients (5%) had Fanconi anemia with the gingiva being the most common location (4/7, 57%). All OSCCs were of keratinizing type. All cases tested for high-risk HPV (n = 34) were negative. On univariate analysis, high tumor budding was associated with decreased overall survival (OS) and distant metastasis free survival (DMFS), pattern of invasion correlated with OS and tumors with high stromal tumor infiltrating lymphocytes (sTIL) were associated with improved locoregional recurrence free survival (LRFS). Compared with patients 31 to 40-year-old, OSCC in the younger group was associated with significant less alcohol consumption (p = 0.011) and decreased DSS (p = 0.003) and DMFS (p = 0.023). On multivariate analysis, younger age (30 years or younger) was an independent prognostic factor for worse OS and DSS, whereas histologic grade was an independent prognostic factor for DSS. In summary, most OSCC in young patients occurred in non-smokers and did not occur in association with Fanconi anemia. Independent prognostic factors included age at presentation (30 years or younger) for OS and DSS, and histologic grade for DSS.
Similar content being viewed by others
References
Myers JN, Elkins T, Roberts D, et al. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg. 2000;122:44–51.
Fang QG, Shi S, Liu FY, et al. Tongue squamous cell carcinoma as a possible distinct entity in patients under 40 years old. Oncol Lett. 2014;7:2099–102.
Schmitd LB, Tjioe KC, and AA, et al. Oral squamous cell carcinoma in young population—risk factors, clinical presentation, and prognosis, contemporary issues in head and neck cancer management. 2015.
Maroun CA, Zhu G, Fakhry C, et al. An immunogenomic investigation of oral cavity squamous cell carcinoma in patients aged 45 years and younger. Laryngoscope. 2020;131(2):304–11.
Udeabor SE, Rana M, Wegener G, et al. Squamous cell carcinoma of the oral cavity and the oropharynx in patients less than 40 years of age: a 20-year analysis. Head Neck Oncol. 2012;4:28.
Ho HC, Lee MS, Hsiao SH, et al. Squamous cell carcinoma of the oral cavity in young patients: a matched-pair analysis. Eur Arch Otorhinolaryngol. 2008;265(Suppl 1):S57-61.
Soudry E, Preis M, Hod R, et al. Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. Clin Otolaryngol. 2010;35:307–12.
Hilly O, Shkedy Y, Hod R, et al. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. Oral Oncol. 2013;49:987–90.
Oliver JR, Wu SP, Chang CM, et al. Survival of oral tongue squamous cell carcinoma in young adults. Head Neck. 2019;41:2960–8.
Subramaniam N, Balasubramanian D, Low TH, et al. Squamous cell carcinoma of the oral tongue in young patients: outcomes and implications for treatment. Indian J Surg Oncol. 2020;11:274–80.
Gamez ME, Kraus R, Hinni ML, et al. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral Oncol. 2018;87:43–8.
Santos HB, dos Santos TK, Paz AR, et al. Clinical findings and risk factors to oral squamous cell carcinoma in young patients: a 12-year retrospective analysis. Med Oral Patol Oral Cir Bucal. 2016;21:e151-156.
Pytynia KB, Grant JR, Etzel CJ, et al. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age. Arch Otolaryngol Head Neck Surg. 2004;130:869–73.
Park JO, Sun DI, Cho KJ, et al. Clinical outcome of squamous cell carcinoma of the tongue in young patients: a stage-matched comparative analysis. Clin Exp Otorhinolaryngol. 2010;3:161–5.
Friedlander PL, Schantz SP, Shaha AR, et al. Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck. 1998;20:363–8.
Siegelmann-Danieli N, Hanlon A, Ridge JA, et al. Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol. 1998;16:745–53.
Martin-Granizo R, Rodriguez-Campo F, Naval L, et al. Squamous cell carcinoma of the oral cavity in patients younger than 40 years. Otolaryngol Head Neck Surg. 1997;117:268–75.
Atula S, Grenman R, Laippala P, et al. Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg. 1996;122:1313–9.
Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck. 1994;16:107–11.
Byers RM. Squamous cell carcinoma of the oral tongue in patients less than thirty years of age. Am J Surg. 1975;130:475–8.
Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29:1488–94.
Scheckenbach K, Wagenmann M, Freund M, et al. Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines. Klin Padiatr. 2012;224:132–8.
Kuriakose M, Sankaranarayanan M, Nair MK, et al. Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol. 1992;28B:113–20.
Vargas H, Pitman KT, Johnson JT, et al. More aggressive behavior of squamous cell carcinoma of the anterior tongue in young women. Laryngoscope. 2000;110:1623–6.
Sun Q, Fang Q, Guo S. A comparison of oral squamous cell carcinoma between young and old patients in a single medical center in China. Int J Clin Exp Med. 2015;8:12418–23.
Nadaf A, Bavle RM, Soumya M, et al. Analysis of the invasive edge in primary and secondary oral squamous cell carcinoma: an independent prognostic marker: a retrospective study. J Oral Maxillofac Pathol. 2016;20:239–45.
Hiratsuka H, Miyakawa A, Nakamori K, et al. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer. 1997;80:351–6.
Bryne M, Koppang HS, Lilleng R, et al. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166:375–81.
Bryne M, Koppang HS, Lilleng R, et al. New malignancy grading is a better prognostic indicator than Broders’ grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989;18:432–7.
Martinez-Gimeno C, Rodriguez EM, Vila CN, et al. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope. 1995;105:728–33.
Kane SV, Gupta M, Kakade AC, et al. Depth of invasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity. Eur J Surg Oncol. 2006;32:795–803.
Chang YC, Nieh S, Chen SF, et al. Invasive pattern grading score designed as an independent prognostic indicator in oral squamous cell carcinoma. Histopathology. 2010;57:295–303.
Sawair FA, Irwin CR, Gordon DJ, et al. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med. 2003;32:1–9.
Jakobsson PA, Eneroth CM, Killander D, et al. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol. 1973;12:1–8.
Odell EW, Jani P, Sherriff M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer. 1994;74:789–94.
Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29:167–78.
Brandwein-Gensler M, Smith RV, Wang B, et al. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 2010;34:676–88.
Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.
Lugli A, Kirsch R, Ajioka Y, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30:1299–311.
Hendry S, Salgado R, Gevaert T, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol. 2017;24:311–35.
O’Regan EM, Timon C, Sheils O, et al. Squamous cell carcinoma of the head and neck in young Irish adults. Br J Oral Maxillofac Surg. 2006;44:203–6.
Hu C, Tian S, Lin L, et al. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma. Oral Oncol. 2020;102:104560.
Troiano G, Rubini C, Togni L, et al. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis. Cancer Med. 2020;8(1):3.
Ou D, Adam J, Garberis I, et al. Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy. Oncoimmunology. 2017;6:e1341030.
McGregor GI, Davis N, Robins RE. Squamous cell carcinoma of the tongue and lower oral cavity in patients under 40 years of age. Am J Surg. 1983;146:88–92.
Spiro RH, Guillamondegui O Jr, Paulino AF, et al. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck. 1999;21:408–13.
Frierson HF Jr, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol. 1986;17:346–54.
Bjerkli IH, Laurvik H, Nginamau ES, et al. Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report. PLoS ONE. 2020;15:e0239783.
Almangush A, Coletta RD, Bello IO, et al. A simple novel prognostic model for early stage oral tongue cancer. Int J Oral Maxillofac Surg. 2015;44:143–50.
Almangush A, Pirinen M, Heikkinen I, et al. Tumour budding in oral squamous cell carcinoma: a meta-analysis. Br J Cancer. 2018;118:577–86.
Ho YY, Wu TY, Cheng HC, et al. The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system. Head Neck. 2019;41:2991–3001.
Garavello W, Spreafico R, Gaini RM. Oral tongue cancer in young patients: a matched analysis. Oral Oncol. 2007;43:894–7.
Lee CC, Ho HC, Chen HL, et al. Squamous cell carcinoma of the oral tongue in young patients: a matched-pair analysis. Acta Otolaryngol. 2007;127:1214–7.
Funding
Research reported in this publication was supported in part by the Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute under award number P30CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have disclosed that they have no significant relationships with, or financial interest in any commercial companies pertaining to this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any conflicts of interest.
Ethical Approval
All procedures performed in this retrospective study involving human participants were approved by the Institutional Review Board (IRB) in our institution. The research did not involve animals. Informed consent can be provided if needed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mneimneh, W.S., Xu, B., Ghossein, C. et al. Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell Carcinoma. Head and Neck Pathol 15, 1099–1108 (2021). https://doi.org/10.1007/s12105-021-01320-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-021-01320-w